Fiera Capital (Canada)
UTHR icon

Fiera Capital (Canada)’s United Therapeutics UTHR Stock Holding History

Fiera Capital (Canada)’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-965
Closed -$297K – 496
2025
Q1 		$297K Hold
965
– – ﹤0.01% 433
2024
Q4 		$340K Sell
965
-479
-33% -$176K ﹤0.01% 420
2024
Q3 		$517K Buy
+1,444
New +$488K ﹤0.01% 389
2017
Q1 		– Sell
-17,886
Closed -$2.57M – 768
2016
Q4 		$2.57M Sell
17,886
-3,056
-15% -$390K 0.01% 421
2016
Q3 		$2.47M Sell
20,942
-162,869
-89% -$19.6M 0.01% 427
2016
Q2 		$19.5M Buy
+183,811
New +$20.5M 0.11% 184

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fiera Capital (Canada)'s UTHR Position: Q2 2025 in Review

Fiera Capital (Canada) sold out of United Therapeutics (UTHR) in Q2 2025, closing a stake of 965 shares — an estimated $297K sold.

Fiera Capital (Canada) first reported a position in UTHR in Q2 2016 and held it in 6 quarters. The position peaked at $19.5M in Q2 2016. 670 funds tracked by Wall St. Rank hold UTHR as of Q2 2025.

  • Fiera Capital (Canada) reported no remaining United Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Fiera Capital (Canada) sold 965 United Therapeutics shares in Q2 2025, an estimated $297K.
  • Fiera Capital (Canada) first reported a position in United Therapeutics in Q2 2016 and held it in 6 quarters.
  • Fiera Capital (Canada)'s United Therapeutics position peaked at $19.5M in Q2 2016.
  • 670 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2025.

Based on Fiera Capital (Canada)'s 13F filing for Q2 2025, filed 8 Aug 2025.